Skip to main content
Thursday, November 12, 2026Nov 12

Wealth may give advantage for getting organ transplants

FILE - In this Oct. 4, 2010 file photo, doctors work on a kidney recently removed from a donor at a hospital in Portland, Ore. A study released on Monday, Nov. 9, 2015, finds that wealthy people are more likely to get on multiple waiting lists and score a transplant, and less likely to die while waiting for one. (Torsten Kjellstrand/The Oregonian via AP, File)
FILE - In this Oct. 4, 2010 file photo, doctors work on a kidney recently removed from a donor at a hospital in Portland, Ore. A study released on Monday, Nov. 9, 2015, finds that wealthy people are more likely to get on multiple waiting lists and score a transplant, and less likely to die while waiting for one. (Torsten Kjellstrand/The Oregonian via AP, File) FILE - In this Oct. 4, 2010 file photo, doctors work on a kidney recently removed from a donor at a hospital in Portland, Ore. A study released on Monday, Nov. 9, 2015, finds that wealthy people are more likely to get on multiple waiting lists and score a transplant, and less likely to die while waiting for one. (Torsten Kjellstrand/The Oregonian via AP, File)

ORLANDO, Fla. (AP) – You can’t buy hearts, kidneys or other organs but money can still help you get one. Wealthy people are more likely to get on multiple waiting lists and score a transplant, and less likely to die while waiting for one, a new study finds.

The work confirms what many have long suspected – the rich have advantages even in a system designed to steer organs to the sickest patients and those who have waited longest. Wealthier people can better afford the tests and travel to get on more than one transplant center’s waiting list, and the new study shows how much this pays off.

“Multiple-listed patients were more likely to get transplanted and less likely to die,” said Dr. Raymond Givens at Columbia University Medical Center in New York.

“It’s a rational thing to do” from an individual patient’s point of view, but it raises fairness questions, and the policy should be reconsidered, he said.

He led the study and gave results Monday at an American Heart Association conference in Orlando.